What is New on Diabetic Neuropathy? Insights from the 2023 ADA and EASD Conferences-Reference-Cited by-同舟云学术

What is New on Diabetic Neuropathy? Insights from the 2023 ADA and EASD Conferences

Published:2024-02-28 Issue: Volume: Page:
ISSN:1534-7346
Container-title:The International Journal of Lower Extremity Wounds
language:en
Short-container-title:The International Journal of Lower Extremity Wounds

Author:

Rebelos Eleni¹²^ORCID,Anastasiou Ioanna A.¹³^ORCID,Tentolouris Anastasios¹,Papanas Nikolaos⁴^ORCID,Jude Edward⁵⁶⁷^ORCID

Affiliation:

1. Diabetes Center, First Department of Propaedeutic Internal Medicine, Medical School, National and Kapodistrian University of Athens, Laiko General Hospital, Athens, Greece

2. Turku PET Centre, University of Turku, Turku, Finland

3. Department of Pharmacology, Medical School, National and Kapodistrian University of Athens, Athens, Greece

4. Diabetes Centre-Diabetic Foot Clinic, Second Department of Internal Medicine, Democritus University of Thrace, Alexandroupolis, Greece

5. Department of Medicine, Tameside and Glossop Integrated Care NHS Foundation Trust, Ashton-under-Lyne, UK

6. University of Manchester, Manchester, UK

7. Manchester Metropolitan University, Manchester, UK

Abstract

Diabetic neuropathy is a common complication of diabetes; yet its pathophysiology is still incompletely understood and until today, there is no specific treatment against it. In the two 2023 large congresses on diabetes (American Diabetes Association, ADA, European Association for the Study of Diabetes, EASD), several high-level studies have been presented. They have attempted to delineate the pathophysiology of DN, the characteristics of affected patients, and future potential treatments. We herein review the presented studies on diabetic neuropathy at these diabetes congresses and discuss the needs for future research on this topic.

Publisher

SAGE Publications

Link

http://journals.sagepub.com/doi/pdf/10.1177/15347346241233938

Reference19 articles.

1. Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021

2. Diabetic neuropathy

3. 323-OR: Association of Silent Myocardial Infarction with Cardiac Autonomic Neuropathy among Asymptomatic Patients with Type 2 Diabetes

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of SLC7A11 in diabetic wound healing: novel insights and new therapeutic strategies;Frontiers in Immunology;2024-09-03

2. Systematic review of translational insights: Neuromodulation in animal models for Diabetic Peripheral Neuropathy;PLOS ONE;2024-08-08